BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23098941)

  • 21. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C; Taillier G; Van Seuningen I; Triboulet JP
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma.
    Korst RJ; Kansler AL; Port JL; Lee PC; Kerem Y; Altorki NK
    Ann Thorac Surg; 2006 Aug; 82(2):480-4; discussion 484-5. PubMed ID: 16863749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of perioperative outcomes following open versus minimally invasive Ivor Lewis oesophagectomy at a single, high-volume centre.
    Sihag S; Wright CD; Wain JC; Gaissert HA; Lanuti M; Allan JS; Mathisen DJ; Morse CR
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):430-7. PubMed ID: 22345284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy.
    Braiteh F; Correa AM; Hofstetter WL; Rice DC; Vaporciyan AA; Walsh GL; Roth JA; Mehran RJ; Swisher SG; Ajani JA
    Cancer; 2009 Oct; 115(19):4450-8. PubMed ID: 19562780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy.
    Tanaka E; Okabe H; Tsunoda S; Obama K; Kan T; Kadokawa Y; Akagami M; Sakai Y
    Asian J Endosc Surg; 2012 Aug; 5(3):111-7. PubMed ID: 22776501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of postoperative morbidity on long-term survival after oesophagectomy.
    Hii MW; Smithers BM; Gotley DC; Thomas JM; Thomson I; Martin I; Barbour AP
    Br J Surg; 2013 Jan; 100(1):95-104. PubMed ID: 23148025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of low-volume surgery for esophageal cancer in a high-volume referral center.
    Courrech Staal EF; van Coevorden F; Cats A; Aleman BM; van Velthuysen ML; Boot H; Peeters MJ; van Sandick JW
    Ann Surg Oncol; 2009 Dec; 16(12):3219-26. PubMed ID: 19777184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
    Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
    Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
    Meredith KL; Weber JM; Turaga KK; Siegel EM; McLoughlin J; Hoffe S; Marcovalerio M; Shah N; Kelley S; Karl R
    Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy.
    Makary MA; Kiernan PD; Sheridan MJ; Tonnesen G; Hetrick V; Vaughan B; Graling P; Elster E
    Am Surg; 2003 Aug; 69(8):693-700; discussion 700-2. PubMed ID: 12953828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies.
    Algan O; Coia LR; Keller SM; Engstrom PF; Weiner LM; Schultheiss TE; Hanks GE
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):753-61. PubMed ID: 7790262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An audit of surgical outcomes of esophageal squamous cell carcinoma.
    Goan YG; Chang HC; Hsu HK; Chou YP
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients.
    Portale G; Hagen JA; Peters JH; Chan LS; DeMeester SR; Gandamihardja TA; DeMeester TR
    J Am Coll Surg; 2006 Apr; 202(4):588-96; discussion 596-8. PubMed ID: 16571425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experience of surgical treatment for cervical esophageal carcinoma].
    Wang WG; Li JD; Qi JX; Luo RH; Gao ZR; Shao LF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):19-23. PubMed ID: 18197487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenocarcinoma of the esophagus and esophagogastric junction in patients older than 70 years: results of neoadjuvant radiochemotherapy followed by transthoracic esophagectomy.
    Camerlo A; D'Journo XB; Ouattara M; Trousse D; Doddoli C; Thomas PA
    J Visc Surg; 2012 Jun; 149(3):e203-10. PubMed ID: 22633088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience.
    Shimada H; Shiratori T; Okazumi S; Matsubara H; Nabeya Y; Shuto K; Akutsu Y; Hayashi H; Isono K; Ochiai T
    J Am Coll Surg; 2008 Jan; 206(1):48-56. PubMed ID: 18155568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy.
    Dittrick GW; Weber JM; Shridhar R; Hoffe S; Melis M; Almhanna K; Barthel J; McLoughlin J; Karl RC; Meredith KL
    Ann Surg Oncol; 2012 May; 19(5):1678-84. PubMed ID: 22045465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.